APY Aspyra,

Aspyra, Inc. (AMEX:APY), a leading provider of clinical and diagnostic information solutions for the healthcare industry, today announced Micah Ciancia has joined the Company as Regional Sales Manager for the South Central U.S. region. Micah Ciancia brings with him over a decade of experience in imaging sales, representing companies such as Agfa Healthcare and GE Healthcare Technologies. Mr. Ciancia stated, �I look forward to contributing to the topline growth of the Company by bringing in new business, as well as building relationships with our current customers and business partners.� Rob Pruter, Senior Vice President of Sales and Marketing for Aspyra, commented, �Micah has the tenacity and experience to effectively promote the Aspyra product solutions and contribute to the sales growth for the Company. Bringing him on board further represents our continued forward movement in the building of a powerful sales and marketing team for Aspyra.� Aspyra solutions provide integrated technologies and services that improve the efficiency, safety and quality of patient care. Aspyra works directly with customers through its own sales and service staff as well as through an extensive partner network. The Company currently counts over 440 customers and over 650 application installations in its installed base. About Aspyra Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com. Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: changes in the Company�s management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company�s long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.